India’s dependency on China for pharma intermediates can change if there is a proper coordination between educational institutes, research institutes and pharma manufacturers
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The base Gland business posted ?11,790 million in revenue, up 16% YoY
A dedicated Life Sciences Innovation Fund, scalable up to Rs. 1,000 crore, will catalyze early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
India’s pharmaceutical sector stands at a pivotal inflection point
CuraTeQ Biologics and BioFactura USA to terminate agreement mutually
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
India plays a critical role in Bristol Myers Squibb’s global strategy
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
Subscribe To Our Newsletter & Stay Updated
